Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-07

Clinical Trial Update: Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing hepatic arterial infusion with Y-90 SIR-spheres plus LV5FU2 versus LV5FU2 alone for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Leucovorin (folinic acid)
  • SIR-Spheres Y-90 resin microspheres (yttrium-90 resin microspheres)

Snippet

Sponsor: Universiteit Antwerpen | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN